Sackler; Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sackler; Richard.The latest application filed is for "pharmaceutical formulation containing irritant".

Company Profile

1.28.19

Sackler; Richard - Greenwich CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulation Containing Irritant App 20190046522 - Sackler; Richard	2019-02-14
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent Grant 10,028,947 - Sackler July 24, 2	2018-07-24
Pharmaceutical formulation containing irritant Grant 10,022,369 - Sackler July 17, 2	2018-07-17
Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Irritant Agent App 20170354654 - Sackler; Richard	2017-12-14
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent Grant 9,737,529 - Sackler August 22, 2	2017-08-22
Pharmaceutical Formulation Containing Irritant App 20170173000 - Sackler; Richard	2017-06-22
Pharmaceutical Formulation Containing Irritant App 20170119756 - Sackler; Richard	2017-05-04
Pharmaceutical formulation containing irritant Grant 9,511,065 - Sackler December 6, 2	2016-12-06
Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Irritant Agent App 20160263103 - Sackler; Richard	2016-09-15
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent Grant 9,326,954 - Sackler May 3, 2	2016-05-03
Pharmaceutical Formulation Containing Irritant App 20150366861 - Sackler; Richard	2015-12-24
Pharmaceutical formulation containing irritant Grant 9,155,717 - Sackler October 13, 2	2015-10-13
Pharmaceutical Formulation Containing Irritant App 20140155426 - Sackler; Richard	2014-06-05
Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Irritant Agent App 20140155425 - Sackler; Richard	2014-06-05
Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent Grant 8,652,515 - Sackler February 18, 2	2014-02-18
Pharmaceutical formulation containing irritant Grant 8,652,497 - Sackler February 18, 2	2014-02-18
Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Irritant Agent App 20120201761 - Sackler; Richard	2012-08-09
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent Grant 8,017,148 - Sackler September 13, 2	2011-09-13
Pharmaceutical Formulation Containing Irritant App 20100261713 - SACKLER; Richard	2010-10-14
Method of treating humans with opioid formulations having extended controlled release Grant 7,740,881 - Sackler , et al. June 22, 2	2010-06-22
Pharmaceutical formulation containing irritant Grant 7,727,557 - Sackler June 1, 2	2010-06-01
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant Grant 7,332,182 - Sackler February 19, 2	2008-02-19
Pharmaceutical formulation containing irritant App 20070020188 - Sackler; Richard	2007-01-25
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent App 20070014732 - Sackler; Richard	2007-01-18
Pharmaceutical formulation containing irritant Grant 7,157,103 - Sackler January 2, 2	2007-01-02
Formulations and methods for providing prolonged local anesthesia Grant 6,921,541 - Chasin , et al. July 26, 2	2005-07-26
Formulation for respiratory tract administration Grant 6,642,275 - Alfonso , et al. November 4, 2	2003-11-04
Formulations and methods for providing prolonged local anesthesia App 20030185873 - Chasin, Mark ; et al.	2003-10-02
Prolonged anesthesia in joints and body spaces App 20030175357 - Goldenhim, Paul ; et al.	2003-09-18
Pharmaceutical formulation containing irritant App 20030068370 - Sackler, Richard	2003-04-10
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant App 20030068392 - Sackler, Richard	2003-04-10
Prolonged anesthesia in joints and body spaces Grant 6,534,081 - Goldenheim , et al. March 18, 2	2003-03-18
Formulations and methods for providing prolonged local anesthesia Grant 6,524,607 - Goldenheim , et al. February 25, 2	2003-02-25
Formulations and methods for providing prolonged local anesthesia Grant 6,521,259 - Chasin , et al. February 18, 2	2003-02-18
Formulations and methods for providing prolonged local anesthesia Grant 6,514,516 - Chasin , et al. February 4, 2	2003-02-04
Prolonged anesthesia in joints and body spaces App 20020054915 - Goldenheim, Paul ; et al.	2002-05-09
Formulation for respiratory tract administration App 20020022663 - Alfonso, Mark ; et al.	2002-02-21
Formulations For Respiratory Tract Administration App 20010049391 - ALFONSO, MARK ; et al.	2001-12-06
Prolonged anesthesia in joints and body spaces Grant 6,248,345 - Goldenheim , et al. June 19, 2	2001-06-19
Method of treating humans with opioid formulations having extended controlled release Grant 6,143,322 - Sackler , et al. November 7, 2	2000-11-07
Formulation for intranasal administration Grant 6,017,963 - Alfonso , et al. January 25, 2	2000-01-25
Formulations and methods for providing prolonged local anesthesia Grant 5,942,241 - Chasin , et al. August 24, 1	1999-08-24
Prolonged local anesthesia with colchicine Grant 5,747,060 - Sackler , et al. May 5, 1	1998-05-05
Emollient antimicrobial formulations containing povidone iodine Grant 5,716,611 - Oshlack , et al. February 10, 1	1998-02-10
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level Grant 5,478,577 - Sackler , et al. December 26, 1	1995-12-26

Company Registrations

SEC

0001634061

SACKLER RICHARD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.